| Literature DB >> 35956867 |
Arash Ebrahimi1, Lukáš Krivosudský1.
Abstract
The emergence of metal-organic frameworks (MOFs) in recent years has stimulated the interest of scientists working in this area as one of the most applicable archetypes of three-dimensional structures that can be used as promising materials in several applications including but not limited to (photo-)catalysis, sensing, separation, adsorption, biological and electrochemical efficiencies and so on. Not only do MOFs have their own specific versatile structures, tunable cavities, and remarkably high surface areas, but they also present many alternative procedures to overcome emerging obstacles. Since the discovery of such highly effective materials, they have been employed for multiple uses; additionally, the efforts towards the synthesis of MOFs with specific properties based on planned (template) synthesis have led to the construction of several promising types of MOFs possessing large biological or bioinspired ligands. Specifically, metalloporphyrin-based MOFs have been created where the porphyrin moieties are either incorporated as struts within the framework to form porphyrinic MOFs or encapsulated inside the cavities to construct porphyrin@MOFs which can combine the peerless properties of porphyrins and porous MOFs simultaneously. In this context, the main aim of this review was to highlight their structure, characteristics, and some of their prominent present-day applications.Entities:
Keywords: (photo-)catalysis; biomimetic; electrochemical utilization; metalloporphyrins; metal–organic frameworks; porphyrins; synthetic strategies
Mesh:
Substances:
Year: 2022 PMID: 35956867 PMCID: PMC9369971 DOI: 10.3390/molecules27154917
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Representative structure of a metalloporphyrin complex with a porphine ligand core.
Figure 2Naturally occurred MPs (metalloporphyrins) (A) iron(II)-porphyrin “Heme B in RBCs” to convey oxygen; (B) magnesium(II)-porphyrin “chlorophyll a” needed for plant photosynthesis; (C) cobalt(II)-porphyrin “methylcobalamin (as vitamin B12)” assisted to facilitate nerve system performances; (D) nickel(II)-porphyrin “Cofactor F430” accelerates methanogenesis in methanogenic archaea). Reprinted with permission from [20].
Naturally occurring metalloporphyrin complexes [27].
| Metal Ion | Ionic Radius (ppm) * | Naturally Occurring Complex |
|---|---|---|
| Mg2+ | 72 | Chlorophyll |
| Ga3+ | 62 | Gallium(III) porphyrin complexes have been found in crude mineral oil but not in living organisms |
| (V=O)2+ | ≈60 | Vanadyl porphyrins are relatively abundant in certain crude oil fractions but they have not been observed in living organisms |
| Fe2+ high spin | 78 (too large) | Fe |
| Co2+ | 65 | Cobalamins (vitamin B12) |
| Ni2+ | 73 | Cofactor F430 (catalyzes the reaction that releases methane in the final step of methanogenesis in archaea), tunichlorin |
* The ideal ionic radius for a proper in-plane coordination is 60–70 ppm. There have also been prepared many artificial complexes containing mostly Mn3+ (≈60 ppm), Cu2+ (73 ppm) and Zn2+ (74 ppm).
Figure 3Examples of some of the previously fabricated porphyrin linkers.
Figure 4Illustrative demonstration of in situ enveloping of metalloporphyrin into ZIF-8 to conjoin CO2 to epoxide. Reprinted with permission from [49].
Figure 5Three basic ways of introduction of open metal sites by PSM synthetic routes to MOFs: (a) cationic guests or organic cations exchange (blue balls) with metal cations (red balls); (b) replacement of a hydroxy protons with Li+ and Mg2+ ions (red balls); (c) chemical reduction of MOM with Li (red balls) and (d) fourth method is a combination of the first two—a collaborative attachment of metal (red balls) chloride (blue ones) salts to anion and cation binding sites. Besides, the sticks and the crescent-shaped bowls attached to sticks are porphyrin-encapsulated inside MOM-11 and cation/anion binding sites. Reprinted with permission from [50].
Figure 6Comparison of free-base PCN-222/MOF-545 (fb-1). (a) Tetrakis(4-carboxyphenyl)porphyrin linker, H4TCPP. (b) [Zr6(m3-O)8(O)8]8¢ node. (c) MOF fb-1, shown across the axis a (d) 3D structure of fb-1, depicted along the c axis. For more clarity hydrogen atoms has been omitted. Reprinted with permission from [54].
Representative list of metalloporphyrin metal–organic frameworks and their applications.
| MOF | Porphyrin | Another Component | Synthetic Procedure | Application | Refs |
|---|---|---|---|---|---|
| Pt(II)TMPyP@rho-ZMOF (In) | TMPyP | 4,5-H3ImDc | In situ | Anion sensing | [ |
| M-TCPP@Cu-MOFs (M = Fe, Ni, Co) | TCPP | H3BTC | In situ | Electrochemical CO2 conversion | [ |
| [TMPyPMn(I)]4+(I−)4@ZIF-8 | TMPyP | In situ | CO2 transformation | [ | |
| (Mn, Co)-TCCP@ZIF-67 | TCPP | In situ | Electrochemical O2 reduction | [ | |
| CoTMPP@ZIF-8 | TMPP | In situ | Water oxidation | [ | |
| PC-MOFs (Zr) | TCPP | Cypate | In situ | PDT/PTT | [ |
| Fe(Salen)@PIZA-1 (Co) | TCPP | In situ | OER | [ | |
| Fe-TPP@ZIF-8-L | TPP | In situ | ORR | [ | |
| FeTCPP@MOF-SA | TCPP | SA | In situ | DNA sensing | [ |
| Fe3O4@CoTHPP@UiO-66 | THPP | Fe3O4 | PSM | Oxidation catalysis | [ |
| Fe-TCCP@NU-1000 | TCPP | PSM | photochemical CO2 reduction | [ | |
| MTX@PCN-221 | TCPP | PSM | Drug delivery | [ | |
| MA-HfMOF-PFC(PFP)-Ni-Zn | PFP and PFC | EDA-maltotriose | PSM | PDT | [ |
| NMOF (Fe)@SF | TCPP | GSH | PSM | CDT/PDT | [ |
| UiO-66@porphyrin | TPP-SH | PSM | PDT | [ | |
| FeTCCP@PCN-333 (Fe) | TCPP | PSM | ORR and HER | [ | |
| PEG–coated-PCN@PL | TCPP | PEG and PL | PSM | Chemo-sonodynamic therapy | [ |
| Hf-NU-1000 (Fe) | TCPP | Porphyrinic | Tandem oxidation catalysis | [ | |
| PCN-222/MOF-545 (fb-1) | TCPP | Porphyrinic | Mustard gas photooxidation | [ | |
| PCN-601, PCN-602 (Ni) | TCPP | Porphyrinic | C-H bond halogenation | [ | |
| USTC-8(In, Cu, Co, Ni, Cd) | TCPP | Porphytinic | H2 photochemical production | [ | |
| PCN-601 (Cu, Co, Fe, Ni) | TPPP | Porphyrinic | Photocatalytic CO2 reduction | [ | |
| PCN-224 (Zr) | TCPP | Vancomycin | Porphyrinic | Antibacterial (PDT) | [ |
| [Cd3(tipp)(bpdc)2]·DMA·9H2O | TIPP | H2bpdc | Porphyrinic | C-C bond formation | [ |
| 2D-Zr-MOFs | TCPP | Porphyrinic | Photocatalytic polymerization | [ | |
| Fe-TBP | TBPP | Porphyrinic | PDT | [ | |
| ZJU-18, ZJU-19 and ZJU-20 | TOCPP | Porphyrinic | Alkylbenzenes oxidation | [ | |
| FTPF (Cu, Nb, Zn) | TPyP | NbOF5 | Porphyrinic | CO2 fixation | [ |
| Cu(TCMOPP) and Ni(TCMOPP) | TCMOPP | Porphyrinic | Alkylbenzenes oxidation | [ |
TMPyP = 5,10,15,20-tetrakis(1-meyhyl-4-pyridinio)porphyrin, THPP = 5,10,15,20-tetrakis(4-hydroxyphenyl)porphyrin, TMPP = 5,10,15,20-tetrakis(4-methoxyphenyl)porphyrin, TPP = 5,10,15,20-tetrakisphenylporphyrin, TCMOPP = 5, 10, 15, 20-tetrakis [4-(carboxymethyleneoxy)phenyl]porphyrin, TBPP = 5,10,15,20-tetrakis(p-benzoato)porphyrin, TOCCP = 5,10,15,20-tetrakis(3,5-biscarboxylphenyl)porphyrin, PFP = 5,15-bis(4-carboxylphenyl)-10,20-bis(pentafluorophenyl)porphyrin, PFC = 5,15-bis(4-carboxylphenyl)-10,20-bis(pentafluorophenyl)chlorin, H2bpdc = biphenyl-4,4-dicarboxylic acid, DMA = N,N-dimethylacetamide, CDT = chemodynamic therapy. PDT = photodynamic therapy, PTT = photothermal therapy, ORR = oxygen reduction reaction, HER = hydrogen evolution reaction, GSH = glutathione, MTX = Methotrexate, PEG = poly(ethylene glycol), PL = piperlongumine, SA = streptavidin, Salen = bis(salicylaldehyde)ethylenediimin.
Figure 7Molecular architecture of (a) PCN-222, (b) NU-902, and (c) MOF-525. (d–f) Attributed Zr6-oxo nodes and the linker (e) carboxylate form of Zn − TCPP) are presented on the right, and (g,h) Lewis acid-catalyzed acyl transfer reaction between pyridylcarbinol (PC) and N-Acylimidazole (NAI) performed by Zirconium-Based (Porphinato)zinc(II) MOF. Reprinted with permission from [80].
Figure 8Fabrication of M@NC (M = Mn and Co) catalysts used for electrocatalysis oxygen reduction reaction in alkaline medium. Reprinted with permission from [59].
Figure 9Schematic presentation of the construction procedure of NMOF@SF NPs and their practical mechanism for tumor-specific redox chemodynamic therapy (CDT) combined with photodynamic therapy (PDT) created by Fe (III)-TCPP and glutathione (GSH) upon laser irradiation. Reprinted with permission from [65].